Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony–Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells

Autor: Talleur, Aimee C., Triplett, Brandon M., Federico, Sara, Mamcarz, Ewelina, Janssen, William, Wu, Jianrong, Shook, David, Leung, Wing, Furman, Wayne L. *
Zdroj: In Biology of Blood and Marrow Transplantation November 2017 23(11):1910-1917
Databáze: ScienceDirect
Externí odkaz: